Acute peripheral ischemia associated with SARS-CoV-2 infection: experience in diagnosis and treatment

Authors

  • Vasile CULIUC IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;
  • Alexandru PREDENCIUC IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;
  • Dumitru CASIAN IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;

DOI:

https://doi.org/10.52692/1857-0011.2023.3-77.28

Keywords:

acute ischemia, COVID-19, surgical treatment

Abstract

The study aimed to evaluate the outcomes of treatment of acute limb ischemia (ALI) in patients with novel coronavirus infection (COVID-19). The study group included 62 patients; 67 extremities: upper - 19 (28.3%), lower - 48 (71.6%).Distribution of cases according to ALI grades (Rutherford): I - 7 (10.4%), IIA - 10 (14.9%), IIB - 34 (50.7%), III - 16 (23.8%). COVID-19 was confirmed by the polymerase chain reaction test; 45 (72.5%) patients being documented to have lung injury. Fifty (80.6%) patients underwent surgical treatment on 52 limbs. Amputation rate during hospitalization (9.4±9 days) - 19.4%; mortality rate - 43.5%, being significantly influenced by the presence or absence of lung damage55.5% vs . 11.7% (P=0.002; χ² test). The following serum biomarkers served as potential predictors of mortality: C-reactive protein to albumin ratio, platelets to lymphocytes and fibrinogen to albumin ratio. At follow-up of 21 (25%-75%IQR 19-28) months overall and amputation-free survival rates were 56.4% and 57.1%.

Author Biographies

Vasile CULIUC, IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;

Doctor of Medical Sciences, Associate Professor at the University; Department of General Surgery and Semiology No.3; Vascular Surgery Section

Alexandru PREDENCIUC, IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;

doctoral student, vascular surgeon;Department of General Surgery and Semiology No.3; Vascular Surgery Section

Dumitru CASIAN, IP USMF "Nicolae Testemitanu"; IMSP Institute of Emergency Medicine;

Doctor of Medical Sciences, University Professor; Department of General Surgery and Semiology No.3; Vascular Surgery Section

References

Phelan A.L., Katz R., Gostin L.O., The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA, 2020; 323:709-10.

WHO. Timeline of WHO’s response to COVID-19. https://www.who.int/news/item/29-06-2020-covidtimeline (accessed December 29, 2020).

Connors J.M., Levy J.H., COVID-19 and its implications for thrombosis and anticoagulation. Blood, 2020; 135:2033-40.

Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger JS., Thrombosis in hospitalized patients with COVID-19 in a New York city Health system. JAMA, 2020; 324(8):799-801.

Bellosta R., Luzzani L., Natalini G. et al., Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg., 2020; 72(6):1864-72.

Björck M., Earnshaw J.J., Acosta S. et al., Editor’s Choice European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur. J. Vasc. Endovasc. Surg., 2020; 59(2):173-218.

Callum K., Bradbury A., ABC of arterial and venous disease: Acute limb ischaemia. BMJ, 2000; 320(7237):764-7.

Borghesi A., Maroldi R., COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. La radiologia medica, 2020; 125(5):509-13.

MedCalc Software Ltd. Comparison of proportions calculator. https://www.medcalc.org/calc/comparison_of_proportions.php (Version 22.009; accessed August 23, 2023)

Chesmedzhieva B., Stanev S., Acute limb ischemia of upper extremity in patients with active COVID-19 infection. Knowledge – International Journal, 2021; 49(4):601-4.

Polyanskaya E.A., Sidorova K.V., Obernina A. P. et al., Results of thrombectomy in lower-extremity ischemia in patients with COVID-19 and respiratory failure of different severity. Russian Journal of Cardiology, 2022; 27(11):5260.

Naouli H., Jiber H., Bouarhroum A., Acute limb ischemia in COVID-19 patients: A single university center experience. Cureus, 2022; 14(12):e32829.

Aimanan K., Mohd Ali N.N.N., Abdul Rahman M.N.A. et al., Acute limb ischemia among COVID-19 patients in Hospital Kuala Lumpur. Open-Access Maced. J. Med. Sci., 2022; 10(B):2387-91.

Goldman I.A., Ye K., Scheinfeld M.H., Lower-extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death. Radiology, 2020; 297:E263-9.

Galyfos G., Sianou A., Frountzas M. et al., Acute limb ischemia among patients with COVID-19 infection. J. Vasc. Surg., 2022; 75(1):326-42.

Pham A., Heib A., Goodman E., Lipsitz E., Indes J., Outcomes of acute limb ischemia in COVID-19. J. Vasc. Surg., 2022; 76(4):1006-13.e3.

Ilonzo N., Judelson D., Al-Jundi W. et al., A review of acute limb ischemia in COVID-positive patients. Semin. Vasc. Surg., 2021; 34(2):8-12.

Klok F.A., Kruip M., van der Meer N.J.M. et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res., 2020; 191:145-7.

Etkin Y., Conway A.M., Silpe J. et al., Acute arterial thromboembolism in patients with COVID-19 in the New York City area. Ann. Vasc. Surg., 2021; 70:290-4.

Gonzalez-Fajardo J.A., Ansuategui M., Romero C. et al., Mortality of COVID-19 patients with vascular thrombotic complications. Med. Clin. (Engl. Ed.), 2021; 156(3):112-7.

Published

2024-01-22

Issue

Section

Research Article

Categories